Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia.
RTI International, Research Triangle Park, North Carolina.
Am J Prev Med. 2017 Sep;53(3S1):S47-S54. doi: 10.1016/j.amepre.2017.05.023.
This study estimated the percentage of breast cancer cases, total number of incident cases, and total annual medical care costs attributable to alcohol consumption among insured younger women (aged 18-44 years) by type of insurance and stage at diagnosis.
The study used the 2012-2013 National Survey on Drug Use and Health, cancer incidence data from two national registry programs, and published relative risk measures to estimate the: (1) alcohol-attributable fraction of breast cancer cases among younger women by insurance type; (2) total number of breast cancer incident cases attributable to alcohol consumption by stage at diagnosis and insurance type among younger women; and (3) total annual medical care costs of treating breast cancer incident cases attributable to alcohol consumption among younger women. Analyses were conducted in 2016; costs were expressed in 2014 U.S. dollars.
Among younger women enrolled in Medicaid, private insurance, and both groups, 8.7% (95% CI=7.4%, 10.0%), 13.8% (95% CI=13.3%, 14.4%), and 12.3% (95% CI=11.4%, 13.1%) of all breast cancer cases, respectively, were attributable to alcohol consumption. Localized stage was the largest proportion of estimated attributable incident cases. The estimated total number of breast cancer incident alcohol-attributable cases was 1,636 (95% CI=1,570, 1,703) and accounted for estimated total annual medical care costs of $148.4 million (95% CI=$140.6 million, $156.1 million).
Alcohol-attributable breast cancer has estimated medical care costs of nearly $150 million per year. The current findings could be used to support evidence-based interventions to reduce alcohol consumption in younger women.
本研究通过保险类型和诊断时的分期，估算了参保年轻女性（18-44 岁）中乳腺癌病例、总发病例数和归因于饮酒的年度医疗费用的比例。
本研究使用了 2012-2013 年国家药物使用与健康调查、两个全国登记计划的癌症发病数据，以及发表的相对风险衡量标准，以估算：（1）按保险类型分类的年轻女性乳腺癌病例中归因于酒精的比例；（2）按诊断时的分期和年轻女性的保险类型分类的归因于酒精的乳腺癌总发病例数；（3）归因于年轻女性饮酒的乳腺癌总发病例的年度医疗费用。分析于 2016 年进行；费用以 2014 年的美元表示。
在参加医疗补助、私人保险和两组保险的年轻女性中，归因于酒精的所有乳腺癌病例分别占 8.7%（95%CI=7.4%，10.0%）、13.8%（95%CI=13.3%，14.4%）和 12.3%（95%CI=11.4%，13.1%）。估计的归因于发病的病例中，局部分期所占比例最大。估计的归因于酒精的乳腺癌总发病例数为 1636 例（95%CI=1570，1703），占估计的年度医疗费用总额 1.484 亿美元（95%CI=1.406 亿美元，1.561 亿美元）。
归因于酒精的乳腺癌每年的医疗费用估计近 1.5 亿美元。目前的研究结果可用于支持基于证据的干预措施，以减少年轻女性的饮酒量。
